Innovation for Health - 13 February 2020
Contact I4H Bootcamp Global Investor Forum
LinkedIn
Twitter
Facebook
Innovation for Health - Shaping the future of healthcare

Markwin Velders

Vice President Operations & Managing Director, Kite Pharma
Markwin Velders

Session

14:45 - 15:35
Biotech breakthroughs

Dr. Markwin Velders brings over 25 years research experience in the field of tumor immunology and over 15 years of management experience in Biotechnology companies. He obtained his PhD from Leiden University in 1996. After a postdoc and associate professorship at Loyola University in Chicago, he was involved in several start-up companies and became Chief Scientific Officer at AM-Pharma in 2004. After bringing two compounds from bench to bed at AM-Pharma, Markwin moved to TNO Biosciences as a Business Unit Manager, managing a group of 150 people. Since 2011 he has been independently active as Prime Life Science, assisting various start-up and early life science companies with their strategy, financing, business development and interim management. He has been involved in the start-up of several new ventures, and secured funding for 4 Life Sciences start-ups.
At th end of 2013 Markwin became involved with a potential start up from NKI that was incorporated in 2014 and called T-cell Factory (TCF) and he was instrumental in the M&A deal where Kite Pharma Inc. acquired TCF to form Kite Pharma EU B.V. Since March 2015 he is Vice President Operations and Managing Director of Kite Pharma EU B.V. in Amsterdam.

Abstract

Peek into the future of CAR-T and the cellular immunotherapy of cancer
I will present the current status of the CAR-T therapy and the limits and promises of the next generation of CAR-T. However, the cellular therapy is not limited to CAR-T and the current progress of the field opens up the opportunities for new approaches and technologies. How will we attack cancer 10 years from now? New therapies are rapidly developing and some aspects will be discussed.
Marcel Levi
University College London Hospitals
Jan van de Winkel
Genmab
Annemarie Jorritsma
NVP
Ton Rijnders
Lygature & Oncode Institute
Koen Kas
UGhent & HealthSkouts
Rajiv Vaid Basaiawmoit
Aarhus University & Biosymfonix

Claudia Rijcken
pharmi

Inge Huitinga
Netherlands Brain Bank
Wiro Niessen
Erasmus MC, TU Delft & Quantib
Els Beirnaert
Aelin Therapeutics
Joep Muijrers
PureTech Health
Koenraad Wiedhaup
McKinsey & Company
Esther Talboom-Kamp
Saltro Diagnostics
Elise Meijer
Antwerp Management School & Accenture Strategy
Carine van den Brink
Axon Lawyers
Tim Knotnerus
AgomAb Therapeutics
Sjaak Vink
TheSocialMedwork
Hans Schikan
Topsector Life Sciences & Health
Thijn Brummelkamp
Scenic Biotech
Nadine Rouleaux
Maastricht University
Charlotte Kluit
MSD
Dharminder Chahal
SkylineDx, Van Herk Investments, Swanbridge

Marianne van der Steen
RegMedXB & Maastricht University

Jan de Kerpel
Kempen & Co
Wim Van Hecke
icoMetrix
Wiesje van der Flier 
Alzheimercentrum Amsterdam
Niels Prins
Brain Research Center & Alzheimercentrum Amsterdam
Marco Blom
Alzheimer Nederland
Edwin Moses
Achilles Therapeutics & Evox Therapeutics
Carl Moons
Health Innovation Initiative Holland
Jan Kimpen
Philips
Linda van de Burgwal 
Vrije Universiteit Amsterdam
Onno van de Stolpe
Galapagos
Ton van der Steen
Erasmus MC, Medical Delta & STW
Sangbreeta Moitra 
Founder, International Keynote Speaker & Global Strategist
Eline Vrijland-van Beest
NightBalance & Philips
Kim Peters
Healthnovum
Gideon Bevelander
Johnson & Johnson Innovation
Giuseppe Marzio
Chiaro
Wijnand IJsselsteijn
Eindhoven University of Technology
Francesco De Rubertis
Medicxi
André van de Sande
André van de Sande Consultancy BV
Travis McCready
President and CEO, Massachusetts Life Sciences Center
Kees van der Klauw
e/MTIC & NL AI Coalition
Maroeska Rovers
Health Innovation Initiative Holland
Christina Takke 
V-Bio Centures
Focco Vijselaar 
Ministerie van Economische Zaken en Klimaat
Juliette Audet 
Forbion
Felice Verduyn 
LSP
Thijs Cohen Tervaert 
INKEF
Tjarda Molenaar
NVP
Willemijn Vader 
VitroScan B.V.
Thomas Hankemeier 
Leiden University
Henk-Jan Guchelaar
Leiden University Medical Center
Jos Lunenberg
ENPICOM BV
Peter de With
Eindhoven University of Technology
Natal van Riel
Eindhoven University of Technology
Bart van Zijll Langhout
Janssen Strategic Alliances EMEA & Janssen NL Campus Lead
Jan Peter Balkenende
Former Prime Minister
Elena Fernandez-Kleinlein
JLABS EMEA
Robert Vries
Hubrecht Organoid Technology
Peter Roevens
Janssen Pharmaceutica NV
Stefan Luzi
Gilde Healthcare
Peter Haasjes
Nextgenventures
Brigitte Drees 
Pivot Park
Femke van de Hoef
Loyens & Loeff
Dries Fransen van de Putte
Loyens & Loeff
Rob de Ree
Biogeneration Ventures
Sponsors & Partners 2020
Host sponsor
Erasmus MC
Host sponsor
Gemeente Rotterdam
Host sponsor
Life Sciences & Health 010
Platinum sponsor
Platinum sponsor
Gold sponsor
Silver sponsor
Silver sponsor
Programme Sponsor AI
Award sponsor
AXON Lawyers
Media sponsor
Powered by
Hyphen Projects
© 2019 Innovation for Health
Hyphen Projects uses cookies to remember certain preferences.